Levoglucosenone and Its Pseudoenantiomer iso-Levoglucosenone as Scaffolds for Drug Discovery and Development
datasetposted on 08.06.2020, 13:36 by Xin Liu, Paul Carr, Michael G. Gardiner, Martin G. Banwell, Ahmed H. Elbanna, Zeinab G. Khalil, Robert J. Capon
The bioderived platform molecule levoglucosenone (LGO, 1) and its readily prepared pseudoenantiomer (iso-LGO, 2) have each been subjected to α-iodination reactions with the product halides then being engaged in palladium-catalyzed Ullmann cross-coupling reactions with various bromonitropyridines. The corresponding α-pyridinylated derivatives such as 11 and 24, respectively, are produced as a result. Biological screening of such products reveals that certain of them display potent and selective antimicrobial and/or cytotoxic properties. In contrast, the azaindoles obtained by reductive cyclization of compounds such as 11 and 12 are essentially inactive in these respects. Preliminary mode-of-action studies are reported.
Read the peer-reviewed publication
pseudoenantiomerScaffoldbromonitropyridinepalladium-catalyzed Ullmann cross-coupling reactionsLevoglucosenoneantimicrobialDrug DiscoverycontrastPseudoenantiomer isocytotoxicbioderived platform molecule levoglucosenoneα- pyridinylated derivativescompoundreductive cyclizationα- iodination reactionsLGOBiological screeningazaindoleproduct halidesdisplayPreliminary mode-of-action studies